Literature DB >> 18984464

Genetic determinants in hepatic fibrosis: from experimental models to fibrogenic gene signatures in humans.

Susanne Weber1, Olav A Gressner, Rabea Hall, Frank Grünhage, Frank Lammert.   

Abstract

Hepatic fibrosis, or scarring of the liver, is a nonspecific reaction to chronic liver injury. Hepatic fibrosis is commonly caused by exogenous factors such as viral hepatitis or alcohol abuse, but recent studies also indicate a genetic predisposition. Although some patients who have chronic liver diseases show only minor morphologic and functional alterations of the liver and are characterized by slow progression of disease with mild clinical symptoms, others develop pronounced hepatic fibrosis rapidly, culminating in cirrhosis, liver failure, or hepatocellular carcinoma, respectively. These well known differences in progression of hepatic fibrosis persist when controlling for age (at infection), gender, and exogenous factors in multivariate analysis, indicating that genetic factors might play important roles in the modulation of hepatic fibrosis and contribute to the variability in fibrosis progression. This review summarizes genetic determinants in hepatic fibrosis.

Entities:  

Mesh:

Year:  2008        PMID: 18984464     DOI: 10.1016/j.cld.2008.07.012

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  18 in total

1.  Identification of RARRES1 as a core regulator in liver fibrosis.

Authors:  Andreas Teufel; Diana Becker; Susanne N Weber; Steven Dooley; Katja Breitkopf-Heinlein; Thorsten Maass; Katrin Hochrath; Markus Krupp; Jens U Marquardt; Martin Kolb; Bernhard Korn; Christof Niehrs; Tim Zimmermann; Patricio Godoy; Peter R Galle; Frank Lammert
Journal:  J Mol Med (Berl)       Date:  2012-06-06       Impact factor: 4.599

2.  Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.

Authors:  Rohit Loomba; Nicholas Schork; Chi-Hua Chen; Ricki Bettencourt; Ana Bhatt; Brandon Ang; Phirum Nguyen; Carolyn Hernandez; Lisa Richards; Joanie Salotti; Steven Lin; Ekihiro Seki; Karen E Nelson; Claude B Sirlin; David Brenner
Journal:  Gastroenterology       Date:  2015-08-20       Impact factor: 22.682

Review 3.  Genome-wide association studies and genetic risk assessment of liver diseases.

Authors:  Marcin Krawczyk; Roman Müllenbach; Susanne N Weber; Vincent Zimmer; Frank Lammert
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

4.  Protect thee from the sins of thy fathers?

Authors:  Scott L Friedman
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

Review 5.  Evolving challenges in hepatic fibrosis.

Authors:  Scott L Friedman
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-06-29       Impact factor: 46.802

6.  Library of molecular associations: curating the complex molecular basis of liver diseases.

Authors:  Stefan Buchkremer; Jasmin Hendel; Markus Krupp; Arndt Weinmann; Kai Schlamp; Thorsten Maass; Frank Staib; Peter R Galle; Andreas Teufel
Journal:  BMC Genomics       Date:  2010-03-20       Impact factor: 3.969

7.  SYSGENET: a meeting report from a new European network for systems genetics.

Authors:  Klaus Schughart
Journal:  Mamm Genome       Date:  2010-07-11       Impact factor: 2.957

8.  Nuclear receptor variants in liver disease.

Authors:  Roman Müllenbach; Susanne N Weber; Frank Lammert
Journal:  J Lipids       Date:  2011-12-21

Review 9.  Bioinformatics tools and database resources for systems genetics analysis in mice--a short review and an evaluation of future needs.

Authors:  Caroline Durrant; Morris A Swertz; Rudi Alberts; Danny Arends; Steffen Möller; Richard Mott; Pjotr Prins; K Joeri van der Velde; Ritsert C Jansen; Klaus Schughart
Journal:  Brief Bioinform       Date:  2011-07-08       Impact factor: 11.622

10.  MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis.

Authors:  Jelena Mann; David C K Chu; Aidan Maxwell; Fiona Oakley; Nian-Ling Zhu; Hidekazu Tsukamoto; Derek A Mann
Journal:  Gastroenterology       Date:  2009-10-17       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.